Kuwait’s New Fast-Track Approval System Follows Regional Trend
Executive Summary
Kuwait is the latest market in the Middle East to introduce a new regulatory procedure for speeding up market entry of innovative new drugs. However, industry experts would like to see it go further.
You may also be interested in...
How Middle Eastern Markets Are Transforming Drug Reviews And Driving Competitiveness
The UAE, Jordan, Egypt and Saudi Arabia have all recently announced or implemented new verification/abridged regulatory pathways to improve access to medicines and free up resources.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.